Results 11 to 20 of about 21,804,485 (185)

Considerations for a Pediatric Biopharmaceutics Classification System (BCS): Application to Five Drugs [PDF]

open access: yesAAPS PharmSciTech, 2014
It has been advocated that biopharmaceutic risk assessment should be conducted early in pediatric product development and synchronized with the adult product development program. However, we are unaware of efforts to classify drugs into a Biopharmaceutics Classification System (BCS) framework for pediatric patients.
Shivani V, Gandhi   +3 more
openaire   +3 more sources

ICH Guideline for Biopharmaceutics Classification System-Based Biowaiver (M9): Toward Harmonization in Latin American Countries

open access: yesPharmaceutics, 2021
The biopharmaceutical classification system (BCS) is a very important tool to replace the traditional in vivo bioequivalence studies with in vitro dissolution assays during multisource product development.
Claudia Miranda   +6 more
doaj   +2 more sources

Solubility, Permeability, and Dissolution Rate of Naftidrofuryl Oxalate Based on BCS Criteria

open access: yesPharmaceutics, 2020
The Biopharmaceutics Classification System (BCS) was conceived to classify drug substances by their in vitro aqueous solubility and permeability properties.
Marta Kus-Slowinska   +5 more
doaj   +2 more sources

Biopharmaceutics classification system: importance and inclusion in biowaiver guidance [PDF]

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2015
Pharmacological therapy is essential in many diseases treatment and it is important that the medicine policy is intended to offering safe and effective treatment with affordable price to the population.
Lorena Barbosa Arrunátegui   +4 more
doaj   +3 more sources

Effect of the Similarity of Formulations and Excipients of Approved Generic Drug Products on In Vivo Bioequivalence for Putative Biopharmaceutics Classification System Class III Drugs

open access: yesPharmaceutics, 2023
One of the potential essential factors that restricts generic industry from applying the Biopharmaceutics Classification System (BCS) Class III biowaiver is adherence to the stringent formulation criteria for formulation qualitative (Q1) sameness and ...
Ping Ren   +8 more
doaj   +2 more sources

Evaluation of the Membrane Permeability (PAMPA and Skin) of Benzimidazoles with Potential Cannabinoid Activity and their Relation with the Biopharmaceutics Classification System (BCS) [PDF]

open access: yesAAPS PharmSciTech, 2011
The permeability of five benzimidazole derivates with potential cannabinoid activity was determined in two models of membranes, parallel artificial membrane permeability assay (PAMPA) and skin, in order to study the relationship of the physicochemical properties of the molecules and characteristics of the membranes with the permeability defined by the ...
Alvarez Figueroa, María Javiera   +5 more
openaire   +6 more sources

Evaluation of changes in oral drug absorption in preterm and term neonates for Biopharmaceutics Classification System (BCS) class I and II compounds [PDF]

open access: yesBritish Journal of Clinical Pharmacology, 2015
AimsEvidence suggests that the rate of oral drug absorption changes during early childhood. Yet, respective clinical implications are currently unclear, particularly for preterm neonates. The objective of this study was to evaluate changes in oral drug absorption after birth for different Biopharmaceutics Classification System (BCS) class I and II ...
Amit A, Somani   +9 more
openaire   +3 more sources

Buccal Absorption of Biopharmaceutics Classification System III Drugs: Formulation Approaches and Mechanistic Insights [PDF]

open access: yesPharmaceutics
Buccal drug delivery emerges as a promising strategy to enhance the absorption of drugs classified under the Biopharmaceutics Classification System (BCS) Class III, characterized by high solubility and low permeability. However, addressing the absorption
Rayan Sabra   +4 more
doaj   +2 more sources

Meeting Report: International Workshop on Implementation of Biowaivers Based on the Biopharmaceutics Classification System (BCS) [PDF]

open access: yesDissolution Technologies, 2015
Even though the pivotal article stating the theoretical basis for a biopharmaceutics drug classification (1) was published almost 20 years ago, the extension of BCS-based biowaiver decisions to drugs belonging to BCS classes other than those showing high solubility and high permeability has not yet reached a consensus among regulators, industrial ...
Cristofoletti, Rodrigo   +7 more
openaire   +3 more sources

Sex‐Related Differences in Physiologically‐Based Biopharmaceutics Modeling [PDF]

open access: yesCPT: Pharmacometrics &Systems Pharmacology, Volume 15, Issue 8, August 2026.
Sex‐related differences in gastrointestinal tract physiology and their incorporation into three widely used PBPK platforms (PK‐Sim, GastroPlus, Simcyp) were evaluated. A ketoprofen PBPK model was developed and verified in males, then extrapolated to females using default and sex‐specific refined parameters, demonstrating that user‐defined adjustments ...
Marianela Chavarría‐Rojas   +4 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy